These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 19343734)
1. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer. Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734 [TBL] [Abstract][Full Text] [Related]
2. Prostate stem cell antigen is overexpressed in prostate cancer metastases. Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638 [TBL] [Abstract][Full Text] [Related]
4. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction. Kusuda Y; Miyake H; Kurahashi T; Fujisawa M Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799 [TBL] [Abstract][Full Text] [Related]
5. PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy. Rybalov M; Ananias HJ; Hoving HD; van der Poel HG; Rosati S; de Jong IJ Int J Mol Sci; 2014 Apr; 15(4):6046-61. PubMed ID: 24727373 [TBL] [Abstract][Full Text] [Related]
6. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer. Zhigang Z; Wenlv S Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669 [TBL] [Abstract][Full Text] [Related]
7. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Ross JS; Sheehan CE; Fisher HA; Kaufman RP; Kaur P; Gray K; Webb I; Gray GS; Mosher R; Kallakury BV Clin Cancer Res; 2003 Dec; 9(17):6357-62. PubMed ID: 14695135 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer. Eder M; Schäfer M; Bauder-Wüst U; Haberkorn U; Eisenhut M; Kopka K Prostate; 2014 May; 74(6):659-68. PubMed ID: 24464532 [TBL] [Abstract][Full Text] [Related]
9. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma. Chang SS; Reuter VE; Heston WD; Gaudin PB Urology; 2001 Jun; 57(6):1179-83. PubMed ID: 11377343 [TBL] [Abstract][Full Text] [Related]
10. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815 [TBL] [Abstract][Full Text] [Related]
11. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice. Yang D; Holt GE; Velders MP; Kwon ED; Kast WM Cancer Res; 2001 Aug; 61(15):5857-60. PubMed ID: 11479226 [TBL] [Abstract][Full Text] [Related]
12. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Gu Z; Thomas G; Yamashiro J; Shintaku IP; Dorey F; Raitano A; Witte ON; Said JW; Loda M; Reiter RE Oncogene; 2000 Mar; 19(10):1288-96. PubMed ID: 10713670 [TBL] [Abstract][Full Text] [Related]
13. Prostate-specific membrane antigen expression in normal and malignant human tissues. Silver DA; Pellicer I; Fair WR; Heston WD; Cordon-Cardo C Clin Cancer Res; 1997 Jan; 3(1):81-5. PubMed ID: 9815541 [TBL] [Abstract][Full Text] [Related]
14. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target. Moore M; Panjwani S; Mathew R; Crowley M; Liu YF; Aronova A; Finnerty B; Zarnegar R; Fahey TJ; Scognamiglio T Endocr Pathol; 2017 Dec; 28(4):339-344. PubMed ID: 28844117 [TBL] [Abstract][Full Text] [Related]
15. Bispecific radioligands targeting prostate-specific membrane antigen and gastrin-releasing peptide receptors on the surface of prostate cancer cells. Liolios C; Sachpekidis C; Schäfer M; Kopka K J Labelled Comp Radiopharm; 2019 Jun; 62(8):510-522. PubMed ID: 31070273 [TBL] [Abstract][Full Text] [Related]
16. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532 [TBL] [Abstract][Full Text] [Related]
17. Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients. Taeb J; Asgari M; Abolhasani M; Farajollahi MM; Madjd Z Pathol Res Pract; 2014 Jan; 210(1):18-23. PubMed ID: 24183365 [TBL] [Abstract][Full Text] [Related]
18. Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade. Schmidt B; Anastasiadis AG; Seifert HH; Franke KH; Oya M; Ackermann R Anticancer Res; 2003; 23(5A):3991-9. PubMed ID: 14666708 [TBL] [Abstract][Full Text] [Related]
19. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases. Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system. Arndt C; Feldmann A; Koristka S; Cartellieri M; Dimmel M; Ehninger A; Ehninger G; Bachmann M Prostate; 2014 Sep; 74(13):1335-46. PubMed ID: 25053443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]